Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Cabot Oil & Gas Co. stock logo
COG
Cabot Oil & Gas
$17.89
$14.28
$23.10
$8.89B0.158.21 million shs1.24 million shs
Genesis Healthcare, Inc. stock logo
GEN
Genesis Healthcare
$23.46
+15.3%
$0.41
$0.40
$1.37
$14.99B0.844.10 million shs13.62 million shs
LexaGene Holdings Inc. stock logo
LXG
LexaGene
C$0.11
-19.2%
C$0.11
C$0.07
C$0.31
C$14.77M2.26170,061 shs2.14 million shs
7 Energy Stocks to Buy and Hold Forever Cover

Do you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Cabot Oil & Gas Co. stock logo
COG
Cabot Oil & Gas
0.00%0.00%0.00%0.00%0.00%
Genesis Healthcare, Inc. stock logo
GEN
Genesis Healthcare
+1.60%+3.35%-10.24%-4.73%+17.98%
LexaGene Holdings Inc. stock logo
LXG
LexaGene
0.00%0.00%0.00%0.00%0.00%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Cabot Oil & Gas Co. stock logo
COG
Cabot Oil & Gas
0.8898 of 5 stars
0.00.01.70.00.60.03.8
Genesis Healthcare, Inc. stock logo
GEN
Genesis Healthcare
1.8285 of 5 stars
2.30.02.50.00.61.71.9
LexaGene Holdings Inc. stock logo
LXG
LexaGene
N/AN/AN/AN/AN/AN/AN/AN/A

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Cabot Oil & Gas Co. stock logo
COG
Cabot Oil & Gas
N/AN/AN/AN/A
Genesis Healthcare, Inc. stock logo
GEN
Genesis Healthcare
2.60
Moderate Buy$26.0010.83% Upside
LexaGene Holdings Inc. stock logo
LXG
LexaGene
N/AN/AN/AN/A

Current Analyst Ratings

Latest LXG, COG, GEN, ABDX, and GDR Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/11/2024
Genesis Healthcare, Inc. stock logo
GEN
Genesis Healthcare
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeOverweight ➝ Equal Weight$28.00 ➝ $25.00
2/12/2024
Genesis Healthcare, Inc. stock logo
GEN
Genesis Healthcare
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$30.00 ➝ $28.00
(Data available from 5/10/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Cabot Oil & Gas Co. stock logo
COG
Cabot Oil & Gas
$1.47B0.00N/A12.93$5.56 per share0.00
Genesis Healthcare, Inc. stock logo
GEN
Genesis Healthcare
$2.80B5.36$2.79 per share8.42($0.16) per share-146.63
LexaGene Holdings Inc. stock logo
LXG
LexaGene
C$110.93K133.13C$0.00 per share21.25C$0.01 per share10.50

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Cabot Oil & Gas Co. stock logo
COG
Cabot Oil & Gas
$200.53M$0.4328.900.000.1919.77%16.52%8.16%N/A
Genesis Healthcare, Inc. stock logo
GEN
Genesis Healthcare
$836M$0.9026.0713.64N/A17.83%155.48%9.12%N/A
LexaGene Holdings Inc. stock logo
LXG
LexaGene
-C$8.54M-C$0.08N/AN/AN/A-339.54%-120.21%N/A

Latest LXG, COG, GEN, ABDX, and GDR Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/9/2024Q4 2024
Genesis Healthcare, Inc. stock logo
GEN
Genesis Healthcare
$0.48$0.48N/A$0.75$965.03 million$967.00 million  

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Cabot Oil & Gas Co. stock logo
COG
Cabot Oil & Gas
$0.44N/AN/A102.33%N/A
Genesis Healthcare, Inc. stock logo
GEN
Genesis Healthcare
$0.502.13%N/A55.56%N/A
LexaGene Holdings Inc. stock logo
LXG
LexaGene
N/AN/AN/AN/AN/A

Latest LXG, COG, GEN, ABDX, and GDR Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
5/9/2024
Genesis Healthcare, Inc. stock logo
GEN
Genesis Healthcare
quarterly$0.12502.46%5/20/20246/12/2024
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Cabot Oil & Gas Co. stock logo
COG
Cabot Oil & Gas
0.41
1.05
1.00
Genesis Healthcare, Inc. stock logo
GEN
Genesis Healthcare
7.50
0.48
0.48
LexaGene Holdings Inc. stock logo
LXG
LexaGene
138.01
1.39
1.13

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Cabot Oil & Gas Co. stock logo
COG
Cabot Oil & Gas
N/A
Genesis Healthcare, Inc. stock logo
GEN
Genesis Healthcare
82.08%
LexaGene Holdings Inc. stock logo
LXG
LexaGene
0.09%

Insider Ownership

CompanyInsider Ownership
Cabot Oil & Gas Co. stock logo
COG
Cabot Oil & Gas
2.10%
Genesis Healthcare, Inc. stock logo
GEN
Genesis Healthcare
3.30%
LexaGene Holdings Inc. stock logo
LXG
LexaGene
17.85%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Cabot Oil & Gas Co. stock logo
COG
Cabot Oil & Gas
503399.66 millionN/AOptionable
Genesis Healthcare, Inc. stock logo
GEN
Genesis Healthcare
2,700639.13 million618.04 millionOptionable
LexaGene Holdings Inc. stock logo
LXG
LexaGene
41140.64 millionN/ANot Optionable

LXG, COG, GEN, ABDX, and GDR Headlines

SourceHeadline
Pamapol Ord Share Price (0LXG)Pamapol Ord Share Price (0LXG)
lse.co.uk - April 9 at 4:12 PM
Biosynex SA ALBIOBiosynex SA ALBIO
morningstar.com - November 12 at 11:42 AM
Cyclopharm Ltd CYCCyclopharm Ltd CYC
morningstar.com - October 31 at 2:22 PM
Lexagene Holdings Inc (LXGh)Lexagene Holdings Inc (LXGh)
investing.com - October 16 at 8:52 AM
Luang Namtha Airport, Luang Namtha, Laos [ LXG / VLLN ]Luang Namtha Airport, Luang Namtha, Laos [ LXG / VLLN ]
prokerala.com - September 15 at 4:50 PM
Eurobio Scientific Bearer and/or Registered shares issued from reverse spliEurobio Scientific Bearer and/or Registered shares issued from reverse spli
morningstar.com - September 2 at 1:48 AM
Zhejiang Gongdong Medical Technology Co Ltd Class AZhejiang Gongdong Medical Technology Co Ltd Class A
morningstar.com - July 28 at 2:20 PM
Global Food Pathogen Detection Technology Market Research ... - The Northwestern ExaminerGlobal Food Pathogen Detection Technology Market Research ... - The Northwestern Examiner
news.google.com - May 7 at 8:15 AM
NA Food Pathogen Testing Market Size, Share, Industry, Forecast to 2029 - openPRNA Food Pathogen Testing Market Size, Share, Industry, Forecast to 2029 - openPR
news.google.com - May 5 at 5:16 PM
Global Point of Care (PoC) Molecular Diagnostics Market Research ... - Yahoo FinanceGlobal Point of Care (PoC) Molecular Diagnostics Market Research ... - Yahoo Finance
news.google.com - May 4 at 8:53 AM
Pathogen Detection System Market 2023-2029 : COVID-19 Impact ... - Industry TodayPathogen Detection System Market 2023-2029 : COVID-19 Impact ... - Industry Today
news.google.com - April 25 at 9:26 AM
Food Pathogen Testing Market Size, Industry Trends, Business Opportunities, Strategies, Key Players Analysis, - openPRFood Pathogen Testing Market Size, Industry Trends, Business Opportunities, Strategies, Key Players Analysis, - openPR
news.google.com - April 14 at 1:27 PM
Bacterial Diagnostics in Aquaculture Professional Market 2031 ... - The SEM WeeklyBacterial Diagnostics in Aquaculture Professional Market 2031 ... - The SEM Weekly
news.google.com - April 13 at 10:43 AM
Aquaculture Bacterial Diagnosis Market 2031 Business Insights with ... - The SEM WeeklyAquaculture Bacterial Diagnosis Market 2031 Business Insights with ... - The SEM Weekly
news.google.com - April 10 at 6:49 PM
Bacterial Diagnostics in Aquaculture Market 2023 With Top Key ... - Digital JournalBacterial Diagnostics in Aquaculture Market 2023 With Top Key ... - Digital Journal
news.google.com - April 10 at 8:48 AM
Bacterial Diagnostics in Aquaculture Market Size Giants Spending Is Going To Boom | Aquasol Corporation, Ziva - openPRBacterial Diagnostics in Aquaculture Market Size Giants Spending Is Going To Boom | Aquasol Corporation, Ziva - openPR
news.google.com - April 5 at 8:44 PM
Food Pathogen Testing Market Is Expected to Grow at a Highest CAGR of 8.0% Size, Share, Growth Statistics, Eme - openPRFood Pathogen Testing Market Is Expected to Grow at a Highest CAGR of 8.0% Size, Share, Growth Statistics, Eme - openPR
news.google.com - April 3 at 12:22 PM
enCore Energys NRC Source Materials License for Dewey-Burdock Project Now Final and Effective - Investing News NetworkenCore Energy's NRC Source Materials License for Dewey-Burdock Project Now Final and Effective - Investing News Network
news.google.com - March 20 at 2:35 PM
Traction Uranium Commences Key Lake South Phase 1 Diamond Drill Program - Investing News NetworkTraction Uranium Commences Key Lake South Phase 1 Diamond Drill Program - Investing News Network
news.google.com - March 8 at 9:54 AM
Global COVID-19 Diagnostics Market 2023: Assay Volumes and 5 ... - Tullahoma News and GuardianGlobal COVID-19 Diagnostics Market 2023: Assay Volumes and 5 ... - Tullahoma News and Guardian
news.google.com - March 2 at 8:30 AM
Beverly biotech company closes, files for bankruptcy | News ... - The Salem NewsBeverly biotech company closes, files for bankruptcy | News ... - The Salem News
news.google.com - February 28 at 7:34 AM
LexaGene Files for Chapter 7 Bankruptcy - Montreal GazetteLexaGene Files for Chapter 7 Bankruptcy - Montreal Gazette
news.google.com - February 24 at 3:44 PM
LexaGene Files for Chapter 7 Bankruptcy - 360DxLexaGene Files for Chapter 7 Bankruptcy - 360Dx
news.google.com - February 24 at 3:44 PM
Molecular Diagnostics Business LexaGene Seeks Liquidation - Bloomberg LawMolecular Diagnostics Business LexaGene Seeks Liquidation - Bloomberg Law
news.google.com - February 24 at 3:44 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

Cabot Oil & Gas logo

Cabot Oil & Gas

NYSE:COG
Cabot Oil & Gas Corp. engages in the development, exploitation, production and exploration of oil and natural gas properties. It operates through the Marcellus shale in Pennsylvania. The company was founded in 1989 and is headquartered in Houston, TX.
Genesis Healthcare logo

Genesis Healthcare

NYSE:GEN
Genesis Healthcare, Inc., together with its subsidiaries, owns and operates skilled nursing facilities and assisted/senior living facilities in the United States. The company operates through three segments: Inpatient Services; Rehabilitation Therapy Services; and Other Services. It also provides a range of rehabilitation therapy services, including speech-language pathology, physical therapy, occupational therapy, and respiratory therapy. In addition, the company offers other specialty medical services, such as physician, staffing, and other healthcare related services. As of December 31, 2020, it provided inpatient services through a network of approximately 341 skilled nursing facilities and assisted/senior living communities in 24 states; and supplied rehabilitation and respiratory therapy to approximately 1,400 healthcare locations in 42 states, the District of Columbia and China. The company was formerly known as FC-GEN Operations Investment, LLC and changed its name to Genesis HealthCare, Inc. in February 2015. Genesis HealthCare, Inc. was founded in 2003 and is headquartered in Kennett Square, Pennsylvania.
LexaGene logo

LexaGene

CVE:LXG
LexaGene Holdings Inc., a biotechnology company, engages in the research, development, and commercialization of pathogen detection systems. It offers MiQLab, an automated pathogen detection system that aims to transform pathogen detection in veterinary diagnostics, human clinical diagnostics, food and water safety testing, and other life sciences markets. Its automated pathogen detection platform is used at the site of sample collection, which offers unprecedented ease-of-use, sensitivity, and breadth of pathogen detection. The company was incorporated in 2007 and is headquartered in Beverly, Massachusetts.